Skip to main content

Table 2 Comparison of results after subgrouping horses due to clinical and light microscopic findings

From: Chlamydophila spp. infection in horses with recurrent airway obstruction: similarities to human chronic obstructive disease

 

n

Histological score: median (span)

IHC (MP): median (span)

IHC (PII): median (span)

IHC (BE): median (span)

IHC (percentage): median (span)

PCR: positive cases (percentage)

Subgroup I

15

0 (0–2)

0 (0–1)

0 (–-4)

6 (–-63)

0.359 (0–4,79)

5 (33.3)

Subgroup II

5

5 (4–6)

0 (0–1)

0 (0–2)

76 (11–119)

4.853 (0.88–8.92)

4 (80)

Subgroup III

16

1 (0–5)

0 (0–1)

0 (0–2)

81.5 (4–474)

6.065 (0.20–25.4)

13 (81.2)

Subgroup IV

9

22 (12–29)

1 (0–4)

22 (0–63)

246 (20–535)

21.024 (1.37–37.1)

2 (22.2)

Mann-Whitney-U *exact Fisher test

 

I vs. II: p < 0.001

I vs. III: p = 0.033

I vs. IV: p < 0.001

II vs. III: p = 0.003

II vs. IV: p = 0.001

III vs. IV: p < 0.001

I vs. II: p = n. s.

I vs. III: p = n. s.

I vs. IV: p = 0.041

II vs. III: p = n. s.

II vs. IV: p = n. s.

III vs. IV: p = 0.037

I vs. II: p = n. s.

I vs. III: p = n. s.

I vs. IV: p < 0.001

II vs. III: p = n. s.

II vs. IV: p = 0.007

III vs. IV: p < 0.001

I vs. II: p = 0.033

I vs. III: p < 0.001

I vs. IV: p < 0.001

II vs. III: p = n. s.

II vs. IV: p = 0.042

III vs. IV: p = 0.023

I vs. II: p = 0.015

I vs. III: p < 0.001

I vs. IV: p < 0.001

II vs. III: p = n. s.

II vs. IV: p = 0.042

III vs. IV: p = 0.020

I vs. II: p = n. s.*

I vs. III: p = 0.019*

I vs. IV: p = n. s.*

II vs. III: p = n. s.*

II vs. IV: p = n. s.*

III vs. IV: p = 0.009*

  1. Subgroup I: Clinically healthy horses without histological changes of RAO
  2. Subgroup II: Clinically healthy horses with a low inflammation score of 4–6
  3. Subgroup III: Horses with clinical signs of RAO, but without or only slight histological changes and a score of 0–5
  4. Subgroup IV: Horses with symptoms and histological changes of RAO with a score > 10
  5. IHC: Number of CP antigen-positive cells in 3 high power fields
  6. MP: macrophages, PII: type II pneumocytes, BE: bronchiolar epithelial cells
  7. IHC (percentage): number of all CP antigen-positive cells in 3 high power fields in relation to all cells